Wu Di, Guan Xiaoqi, Yang Tao, Yan Jiashuai, Zhu Biwen, Zhou Junchao, Guo Yibing, Lu Yuhua
Department of Hepatobiliary and Pancreatic Surgery, Affiliated Hospital of Nantong University, Medical School of Nantong University, Nantong 226001, PR China.
Research Center of Clinical Medicine, Affiliated Hospital of Nantong University, Nantong, Jiangsu province 226001, PR China.
Mater Today Bio. 2025 Aug 5;34:102176. doi: 10.1016/j.mtbio.2025.102176. eCollection 2025 Oct.
Cancer stem cells (CSCs), the primary source of therapy resistance in pancreatic ductal adenocarcinoma (PDAC), exist in a dynamic equilibrium through tumor microenvironment (TME)-driven plasticity. However, the stiffness heterogeneity of TME within PDAC functions on tumor cell stem-like phenotypes remains unclear. Bioinformatics, including Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) analysis, of CSCs identified from spatial transcriptomic and single-cell datasets of PDAC lesions exhibited activated mechanical and glycolytic pathways. Detected by the nano-indenter, PDAC tissue exhibited significant stiffness heterogeneity (200-6000 Pa). Further, biomimetic local stiffness niches were engineered using the digital light-processing (DLP) 3D-printing technology and the desmoplastic bioink (gelatin methacrylate & hyaluronic acid methacrylate, GelMA&HAMA) encapsulating PDAC cells, which permits modulation of mechanical properties without altering the biochemical ligand density. Stemness markers (NANOG, OCT4), glycolysis genes (HK2, LDHA), YAP1, and N6-methyladenosine (m6A) regulators (METTL14, IGF2BP3) were evaluated via qRT-PCR and immunofluorescence. Functional assays of glycolysis and stem-like phenotype were also conducted. Dot blot, RNA stability assay, western blot, and RIP assay were exploited to clarify the level and the function of m6A modification. The local stiff niche enhanced the stem-like phenotype of PDAC cells via YAP1-boosted glycolysis. Mechanistically, local stiff niche elevated the YAP1 level via m6A (METTL14/IGF2BP3)-stabilized YAP1 mRNA, linking mechanical inputs to glycolytic-stem-like phenotype adaptations. Collectively, the local stiff niches may drive the emergence of CSCs through epigenetic and metabolic reprogramming in PDAC mechanobiology. This provides new insights for developing more precise therapeutic strategies targeting PDAC mechanical heterogeneity.
癌症干细胞(CSCs)是胰腺导管腺癌(PDAC)治疗耐药性的主要来源,通过肿瘤微环境(TME)驱动的可塑性处于动态平衡中。然而,PDAC内TME的硬度异质性对肿瘤细胞干细胞样表型的作用仍不清楚。对从PDAC病变的空间转录组和单细胞数据集中鉴定出的CSCs进行生物信息学分析,包括基因本体论(GO)和京都基因与基因组百科全书(KEGG)分析,显示机械和糖酵解途径被激活。通过纳米压痕仪检测,PDAC组织表现出显著的硬度异质性(200 - 6000 Pa)。此外,利用数字光处理(DLP)3D打印技术和包裹PDAC细胞的促结缔组织增生生物墨水(甲基丙烯酸明胶和甲基丙烯酸透明质酸,GelMA&HAMA)构建了仿生局部硬度微环境,这允许在不改变生化配体密度情况下调节机械性能。通过qRT-PCR和免疫荧光评估干细胞标志物(NANOG、OCT4)、糖酵解基因(HK2、LDHA)、YAP1和N6 - 甲基腺苷(m6A)调节剂(METTL14、IGF2BP3)。还进行了糖酵解和干细胞样表型的功能测定。利用斑点印迹、RNA稳定性测定、蛋白质印迹和RIP测定来阐明m6A修饰的水平和功能。局部硬微环境通过YAP1增强的糖酵解增强了PDAC细胞的干细胞样表型。机制上,局部硬微环境通过m6A(METTL14/IGF2BP3)稳定的YAP1 mRNA提高YAP1水平,将机械输入与糖酵解 - 干细胞样表型适应联系起来。总体而言,局部硬微环境可能通过PDAC力学生物学中的表观遗传和代谢重编程驱动CSCs的出现。这为开发针对PDAC机械异质性的更精确治疗策略提供了新见解。